1
/
of
0
FDA Drug/Biologics Approval BLA 125387 S-020, AFLIBERCEPT
FDA Drug/Biologics Approval BLA 125387 S-020, AFLIBERCEPT
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 125387 S-020
Company: REGENERON PHARMACEUTICALS
Drug Name: EYLEA
Active Ingredients: AFLIBERCEPT
Strength: 40MG/ML
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 11/18/2011
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: REGENERON PHARMACEUTICALS
Drug Name: EYLEA
Active Ingredients: AFLIBERCEPT
Strength: 40MG/ML
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 11/18/2011
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details